BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1448491)

  • 1. Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task.
    Pitsikas N; Algeri S
    Pharmacol Biochem Behav; 1992 Nov; 43(3):949-51. PubMed ID: 1448491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task.
    Pitsikas N; Brambilla A; Borsini F
    Pharmacol Biochem Behav; 1994 Jan; 47(1):95-9. PubMed ID: 8115433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze.
    Bartolini L; Risaliti R; Pepeu G
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1161-4. PubMed ID: 1475299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.
    Preda L; Alberoni M; Bressi S; Cattaneo C; Parini J; Canal N; Franceschi M
    Psychopharmacology (Berl); 1993; 110(4):421-6. PubMed ID: 7870912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine.
    Giovannini MG; Spignoli G; Carlà V; Pepeu G
    Pharmacol Res; 1991 Dec; 24(4):395-405. PubMed ID: 1805193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats.
    Yavich L; Sirviö J; Heinonen E; Riekkinen P
    J Neural Transm Park Dis Dement Sect; 1993; 6(3):189-97. PubMed ID: 8123192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice.
    Hlinák Z; Krejcí I
    Behav Brain Res; 2002 Jul; 133(2):395-9. PubMed ID: 12110475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat.
    Yamaguchi Y; Kobayashi H
    Neuropeptides; 1994 Mar; 26(3):153-8. PubMed ID: 8208360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
    Dennes RP; Barnes JC
    Psychopharmacology (Berl); 1993; 111(4):435-41. PubMed ID: 7870985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice.
    de Angelis L; Furlan C
    Neurobiol Learn Mem; 1995 Sep; 64(2):119-24. PubMed ID: 7582819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats.
    Xiong ZQ; Tang XC
    Pharmacol Biochem Behav; 1995; 51(2-3):415-9. PubMed ID: 7667362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35,926 (CI-979).
    M'Harzi M; Palou AM; Oberlander C; Barzaghi F
    Pharmacol Biochem Behav; 1995 May; 51(1):119-24. PubMed ID: 7617721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional modulation of scopolamine-induced working memory impairments by muscarinic activation of the medial septal area.
    Givens B; Olton DS
    Neurobiol Learn Mem; 1995 May; 63(3):269-76. PubMed ID: 7670840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats.
    Egawa T; Mishima K; Matsumoto Y; Iwasaki K; Iwasaki K; Fujiwara M
    Jpn J Pharmacol; 1997 Nov; 75(3):275-81. PubMed ID: 9434259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of hippocampally-mediated learning and protein kinase C activity by oxiracetam in learning-impaired DBA/2 mice.
    Fordyce DE; Clark VJ; Paylor R; Wehner JM
    Brain Res; 1995 Feb; 672(1-2):170-6. PubMed ID: 7749739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of (R)-alpha-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze.
    Smith CP; Hunter AJ; Bennett GW
    Psychopharmacology (Berl); 1994 May; 114(4):651-6. PubMed ID: 7855228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the behavioral effects of cognition-enhancing drugs and brain acetylcholine. Nootropic drugs and brain acetylcholine.
    Pepeu G; Spignoli G; Giovannini MG; Magnani M
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():116-9. PubMed ID: 2602443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of cholinergic function in spatial and procedural learning in rats.
    von Linstow Roloff E; Harbaran D; Micheau J; Platt B; Riedel G
    Neuroscience; 2007 May; 146(3):875-89. PubMed ID: 17418958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.